Welcome to the Institute of Clinical Research

Welcome to the Institute of Clinical Research

About Us

The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.  

For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community.  For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.

It is the membership that makes the Institute.

How does it all work ?

The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.

The Board is made up of members who give their time freely to guide the future direction of the ICR.

The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.

  

Our Mission

The ICR exists to support our members through all stages of their careers. We do this, in part, by:

  • Defining and refining standards for our profession
  • Providing a forum for discussion of key issues impacting clinical research
  • Promoting good relations with other healthcare related groups 
  • Providing opportunities for learning and development to enhance professional competence 
  • Enhancing public confidence and understanding of clinical research

 

Current News

How a top FDA official’s words helped push a closely watched ALS drug toward approval

By ICR Secretariat / 20/09/2022 03:21 PM

The meeting was already unusual. Convened by the Food and Drug Administration Wednesday, a group of independent experts were, for a rare second time, …

ESMO: Bristol Myers, Roche fail in post-surgery kidney cancer. But is it good news for Merck's Keytruda?

By ICR Secretariat / 20/09/2022 03:20 PM

Bristol Myers Squibb's and Roche's immunotherapies have both failed to move the needle when used after surgery in early-stage kidney cancer. But the t…

Stada launches prostate cancer treatment across 21 European countries

By ICR Secretariat / 20/09/2022 03:13 PM

Stada is broadening its offering to patients, pharmacists and physicians in Europe by introducing abiraterone acetate 500mg film-coated tablets in 21 …


Boehringer Ingelheim finally has skin in the game, scoring its first dermatology FDA nod

By ICR Secretariat / 08/09/2022 02:21 PM

When the subject is skin disorders, Boehringer Ingelheim isn’t the first company that comes to mind. But Thursday, the world’s largest privately owned…

Novartis’ Bradner steps down as research head amid company shake-up

By ICR Secretariat / 08/09/2022 02:17 PM

Jay Bradner is stepping down as head of the Novartis Institutes of BioMedical Research after more than six years steering the Swiss pharmaceutical com…

Pfizer shifts oncology chief Schmeltz to new strategy role as rare disease head Varma fills in

By ICR Secretariat / 08/09/2022 02:13 PM

Executive reshuffling continues at Pfizer.

After four years as global president of Pfizer oncology, Andy Schmeltz is moving into a new role as senior …


ESC 2022: Bayer's Kerendia cuts risk of sudden cardiac death in patients with chronic kidney disease and type 2 diabetes

By ICR Secretariat / 05/09/2022 10:30 AM

While Bayer’s Kerendia can’t match the efficacy figures of other chronic kidney disease (CKD) drugs such as AstraZeneca’s Farxiga, the company believe…

MIT’s AI model can detect Parkinson’s by tracking breathing patterns

By ICR Secretariat / 05/09/2022 10:28 AM

A team of researchers from the Massachusetts Institute of Technology (MIT), in collaboration with the University of Rochester, Mayo Clinic and Massach…

US earmarks up to $680M for Chimerix's smallpox drug Tembexa, clearing way for Emergent buyout

By ICR Secretariat / 05/09/2022 10:26 AM

During the latest monkeypox outbreak, doctors in the U.S. have been treating patients with Siga Technologies’ smallpox drug Tpoxx. Now, the U.S. gover…


NHS leaders urge government to act or risk public health emergency

By ICR Secretariat / 30/08/2022 11:01 AM

NHS leaders from across England, Wales and Northern Ireland are warning of rising numbers of people falling ill and worsening health outcomes across t…

Axsome rebounds to win FDA approval of depression drug

By ICR Secretariat / 30/08/2022 11:00 AM

The Food and Drug Administration on Friday approved a new depression drug from Axsome Therapeutics, one year after putting the treatment in regulatory…

New study use musical tests for early detection of cognitive decline

By ICR Secretariat / 30/08/2022 10:58 AM

Researchers at Tel Aviv University have created a method which uses musical tests and a portable brain activity-measuring device to detect cognitive d…


NICE recommendation expands patient eligibility for AbbVie’s Ozurdex

By ICR Secretariat / 18/08/2022 03:38 PM

AbbVie has announced that the National Institute for Health and Care Excellence (NICE) has issued a final appraisal document recommending the dexameth…

Amgen’s low tax rates draw attention of top Democratic senator

By ICR Secretariat / 18/08/2022 03:23 PM

Last year, Amgen paid taxes equivalent to just over 12% of its nearly $7 billion in pre-tax profits, well below the U.S. corporate rate of 21%. The ye…

2 deaths after Novartis' Zolgensma put gene therapy's liver safety in the spotlight once again

By ICR Secretariat / 18/08/2022 03:16 PM

Novartis has recorded two deaths after treatment with its spinal muscular atrophy gene therapy Zolgensma, once again bringing gene therapy’s safety in…


FDA approves AstraZeneca, Daiichi drug in breast cancer first

By ICR Secretariat / 11/08/2022 03:28 PM

A new targeted treatment for breast cancer could reshape how doctors classify and treat the disease, offering another option for people whose tumors h…

The most significant FDA citations of 2021-2022

By ICR Secretariat / 11/08/2022 02:31 PM

While the FDA's inspection activities suffered amid the COVID-19 pandemic, several notable citations surfaced over the past year and a half. Those reb…

How a small UK biotech ended up in Gilead’s hands

By ICR Secretariat / 11/08/2022 02:21 PM

Gilead Sciences will acquire U.K.-based startup MiroBio, which is developing antibody drugs for autoimmune disorders, in a $405 million deal announced…


Aiming to avoid Pfizer's Eucrisa failure, Arcutis wins FDA nod for Zoryve cream in psoriasis

By ICR Secretariat / 04/08/2022 01:38 PM

Pfizer once harbored blockbuster hopes for Eucrisa to be the next big topical treatment for inflammatory skin diseases. But the ointment never gained …

Tallac announces first patient treated with TAC-001

By ICR Secretariat / 04/08/2022 01:29 PM

Tallac Therapeutics has announced that the first patient has been treated with TAC-001 in a phase 1/2 clinical trial for patients with advanced or met…

US secures updated COVID boosters in $1.7B deal with Moderna

By ICR Secretariat / 04/08/2022 01:15 PM

The U.S. government has reached a deal with Moderna to buy 66 million doses of the biotechnology company’s updated COVID-19 booster shot this year, pr…


ICR Autumn ONLINE Ethics & GCP Forum

By ICR Secretariat / 01/08/2022 03:53 PM

We are delighted to announce that we will be running our Autumn Ethics & GCP Forum online via Zoom on the 11th October 2022. If you are unavailabl…

FDA puts the microscope on 2 more cancer approvals without voluntary withdrawals

By ICR Secretariat / 01/08/2022 03:50 PM

The FDA’s oncology department has lately been tightening its act around accelerated approvals and stressing the importance of patient survival data. S…

NHS app reaches new milestone

By ICR Secretariat / 01/08/2022 03:48 PM

The NHS App enabled 1.8 million repeat prescriptions to be ordered in June 2022 alone


After failed Alzheimer's launch, Biogen writes off the remaining value of its Aduhelm inventory

By ICR Secretariat / 01/08/2022 03:37 PM

Biogen is trying to escape the dark Aduhelm cloud hanging over its Alzheimer's disease drug launch. So far, the launch has triggered layoffs, a CEO sw…

ICR Project Management Forum - Friday 30th September at IQVIA - Reading

By ICR Secretariat / 30/05/2022 02:56 PM

We are pleased to announce our annual Project Management Forum will be held on

Friday 30th September at IQVIA - Reading

Understanding Project Manageme…

Course Postponements Due to Covid

By ICR Secretariat / 10/02/2022 03:38 PM

All of our delegates and members who had course places postponed over the last two years due to covid restrictions/illness have now been contacted dir…




Events and Courses

Advanced Monitoring L29

In this highly practical course we look at the root cause of typical inspection findings and work with delegates to develop personal corrective a...


Project Management Forum CT

Understanding Project Management can be a ni...


The ICR Ethics & GCP Forum EGCP

The ICR Ethics and GCP Forum provides an excellent opportunity to:  Keep up to date with current ethical and clinical r...


The Essentials of Trial Master File (TMF) Management L25

The MHRA GCP Inspectorate has updated their definition of critical to include, ‘where provision of the Trial Master File (TMF) does not comply wi...


ISO-14155:2011 - Clinical Investigation of Medical Devices for Human Subjects - Good Practice L26

Approximately 1.5 million different medical devices are available globally; with thousands of new and innovative medical devices being introduced t...


Essentials of Clinical Trial Monitoring L27

This practical course defines the role of the clinical research monitor and explains the interaction with others in key roles as part of the clinical ...


Current Jobs